Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review.

Caughey MC, Poole C, Ataga KI, Hinderliter AL.

Br J Haematol. 2015 Aug;170(3):416-24. doi: 10.1111/bjh.13447. Epub 2015 Apr 9. Review.

PMID:
25854714
2.

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP.

N Engl J Med. 2004 Feb 26;350(9):886-95.

3.

Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.

Desai PC, May RC, Jones SK, Strayhorn D, Caughey M, Hinderliter A, Ataga KI.

Br J Haematol. 2013 Sep;162(6):836-41. doi: 10.1111/bjh.12453. Epub 2013 Jul 6.

4.

Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.

Elbarbary NS, Ismail EA, Roushdy A, Fahmy E.

Blood Cells Mol Dis. 2016 Mar;57:1-7. doi: 10.1016/j.bcmd.2015.11.001. Epub 2015 Nov 10.

PMID:
26852648
5.

Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.

Olnes M, Chi A, Haney C, May R, Minniti C, Taylor J 6th, Kato GJ.

Am J Hematol. 2009 Aug;84(8):530-32. doi: 10.1002/ajh.21446. No abstract available.

6.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

7.

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730.

PMID:
18381543
8.

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.

Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.

Health Technol Assess. 2012;16(43):1-129. doi: 10.3310/hta16430. Review.

9.

The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.

Lobo CL, Pinto JF, Nascimento EM, Moura PG, Cardoso GP, Hankins JS.

Br J Haematol. 2013 Jun;161(6):852-60. doi: 10.1111/bjh.12323. Epub 2013 Apr 17.

PMID:
23590693
10.

Misclassification of pulmonary hypertension in adults with sickle hemoglobinopathies using Doppler echocardiography.

Fitzgerald M, Fagan K, Herbert DE, Al-Ali M, Mugal M, Haynes J Jr.

South Med J. 2012 Jun;105(6):300-5. doi: 10.1097/SMJ.0b013e318256b55b.

PMID:
22665152
11.

Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.

Aliyu ZY, Gordeuk V, Sachdev V, Babadoko A, Mamman AI, Akpanpe P, Attah E, Suleiman Y, Aliyu N, Yusuf J, Mendelsohn L, Kato GJ, Gladwin MT.

Am J Hematol. 2008 Jun;83(6):485-90. doi: 10.1002/ajh.21162.

12.

Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.

Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L.

Pediatr Blood Cancer. 2006 Dec;47(7):907-13.

PMID:
16496290
13.

Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.

Dahoui HA, Hayek MN, Nietert PJ, Arabi MT, Muwakkit SA, Saab RH, Bissar AN, Jumaa NM, Farhat FS, Dabbous IA, Bitar FF, Abboud MR.

Pediatr Blood Cancer. 2010 Mar;54(3):398-402. doi: 10.1002/pbc.22306.

PMID:
19827138
14.

Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Br J Haematol. 2009 Mar;144(5):736-41. doi: 10.1111/j.1365-2141.2008.07501.x. Epub 2008 Dec 1.

PMID:
19055665
15.

The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.

Musa BM, Galadanci NA, Coker M, Bussell S, Aliyu MH.

Ann Hematol. 2016 Oct;95(11):1757-64. doi: 10.1007/s00277-016-2693-z. Epub 2016 May 16. Review.

PMID:
27181705
16.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M.

JAMA. 2003 Apr 2;289(13):1645-51. Erratum in: JAMA. 2003 Aug 13;290(6):756.

PMID:
12672732
17.

Hydroxycarbamide use in young children with sickle-cell anaemia.

Takahashi Y, Mori J, Tsubokura M, Matsumura T, Kami M.

Lancet. 2011 Nov 19;378(9805):1777. doi: 10.1016/S0140-6736(11)61771-6. No abstract available.

PMID:
22098851
18.

Hydroxycarbamide use in young children with sickle-cell anaemia.

Obaro SK, Inusa B, Telfer P.

Lancet. 2011 Nov 19;378(9805):1777. doi: 10.1016/S0140-6736(11)61770-4. No abstract available.

PMID:
22098850
19.

High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease.

Bolignano D, Lennartz S, Leonardis D, D'Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C.

Kidney Int. 2015 Jul;88(1):130-6. doi: 10.1038/ki.2015.27. Epub 2015 Feb 18.

PMID:
25692957
20.

Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought?

Hebson C, New T, Record E, Oster M, Ehrlich A, Border W, James-Herry A, Kanaan U.

J Pediatr Hematol Oncol. 2015 Mar;37(2):134-9. doi: 10.1097/MPH.0000000000000184.

PMID:
24942020

Supplemental Content

Support Center